Although AGC2 deficiency, leading to type 2 citrullinemia, has been linked to hepatocellular carcinoma [131], it is hypothesized that this might be due to the reactivation of AGC1 [132]. This evidence concerns the gene SLC25A12 and hepatocellular carcinoma.